TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Peter Hagedorn
Senior Principal Scientist, Group Leader at Roche Innovation Center Copenhagen A/S

Profile

Peter Hagedorn is a Senior Principal Scientist at Roche Innovation Center Copenhagen. He leads a team of RNA biologists and bioinformaticians exploring oligonucleotide engagement mechanisms, interactions, and design strategies. Research in his team is currently focused on custom development of massively-parallel sequencing methods to evaluate RNA target sequence and oligonucleotide properties. Data from such applications are used to build structure-effect machine learning models for computational prediction of drug properties. Peter holds a master’s degree from 2002 in Biophysics from the Niels Bohr Institute, University of Copenhagen, Denmark. In 2006 he obtained his PhD in Molecular Biology and Bioinformatics from the University of Southern Denmark.

Peter Hagedorn's Network

Agenda Sessions

  • Machine Learning-guided Design of Antisense Oligonucleotides

    , 14:00